Immucell (ICCC) Profit After Tax Growth (5y) (2015 - 2026)
Powered by 
Analysis
Immucell (ICCC) Profit After Tax Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67.03% |
| Dec 31, 2025 | -76.42% |
| Sep 30, 2025 | 15.42% |
| Jun 30, 2025 | 21.57% |
| Mar 31, 2025 | 69.12% |
| Dec 31, 2024 | 29.61% |
| Sep 30, 2024 | -6.90% |
| Jun 30, 2024 | -19.55% |
| Mar 31, 2024 | -38.13% |
| Dec 31, 2023 | -1.61% |
| Sep 30, 2023 | -30.33% |
| Jun 30, 2023 | -11.56% |
| Mar 31, 2023 | -59.95% |
| Dec 31, 2022 | -53.67% |
| Sep 30, 2022 | -14.06% |
| Jun 30, 2022 | -25.66% |
| Mar 31, 2022 | -2.56% |
| Dec 31, 2021 | 19.61% |
| Sep 30, 2021 | 33.48% |
| Jun 30, 2021 | 77.08% |